Changing Landscape of Management in Eye Diseases: Glaucoma, Ocular Surface Disease, Neurotrophic Keratitis, Cataract Surgery, and Vitreoretinal Surgery

Complimentary

Enduring Webcast
Released on 12/1/25
Expires on 12/1/26

Categories: , , , , , , , , , , , ,
Changing Landscape of Management in Eye Diseases: Glaucoma, Ocular Surface Disease, Neurotrophic Keratitis, Cataract Surgery, and Vitreoretinal Surgery

Take Me to the Event Registration

Program Description

Eye diseases encompass a wide range of conditions that can affect various parts of the eye, potentially leading to vision loss or other complications. Common eye diseases include cataracts, glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy, ocular surface disease, and neurotrophic keratitis. Symptoms can vary widely but may include blurry vision, eye pain, redness, and changes in visual field. This enduring webcast will provide up-to-date, evidence-based information on the changing landscape of eye diseases.

Intended Audience

Ophthalmologists, optometrists, advanced practice providers (physician assistants and nurse practitioners), nurses, and pharmacists who manage patients with eye diseases

Commercial Supporter

Supported by an unrestricted educational grant from Alcon Vision, LLC, and Dompé US, Inc.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Summarize the clinical presentation, topical agents, sustained-release drug delivery systems, and surgical approaches in managing glaucoma
  • Assess the tear film’s functional integrity, corneal homeostasis, and ocular surface disease.
  • Interpret testing procedures, artificial tear formulations, and neuromodulation in managing ocular surface disease.
  • Outline the diagnosis and emerging treatments for the neurotrophic keratitis.
  • Appraise the types of cataracts, imaging, and innovations in cataract surgery.
  • Outline the complications of cataract surgery and management by a vitreoretinal surgeon.

Accredited Providers

This activity is jointly provided by Amedco and MedNet.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco and MedNet. Amedco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians Credit Designation

Amedco designates this enduring material for a maximum of 3.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses Credit Designation

This activity is awarded 3.50 contact hours (based on 60 minutes per contact hour).

Additional Credit Information

Note to Physician Assistants
 

PAs may claim a maximum of 3.50 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.

Note to Nurse Practitioners
 

The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allows reciprocity for AANPCP continuing education credit. 3.50 hours.

Through an agreement between the American Medical Association (AMA) and the European Union of Medical Specialists, physicians and healthcare providers may convert CME/CE AMA PRA Category 1 CreditsTM to an equivalent number of European CME Credits® (ECMECs®). The UEMS-EACCME® has recognition agreements with the AMA for live events and e-learning materials.

Conflicts of Interest Disclosure Policy

Amedco and MedNet adhere to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME/CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Accredited Provider Disclosures

None of the planners, reviewers, and Amedco staff for this educational activity have relevant financial relationship(s) with ineligible companies to disclose.

Planners’ and Managers’ Disclosures

None of the planners, reviewers, and MetNet staff for this educational activity have relevant financial relationship(s) with ineligible companies to disclose.

Disclosure of Unlabeled Use

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a clinician relative to diagnostic and treatment options for a specific patient’s medical condition.

Disclaimer

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Amedco or MedNet. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

If you have any questions relating to the accreditation of this activity, please contact info@mmhus.net.

Faculty

 

Eric D. Donnefeld, MD
Clinical Professor of Ophthalmology
New York University Langone Medical Center
Ophthalmic Consultants of Long Island
New York, NY

Dr. Donnefeld discloses the following:

Speaker: Allegro, Abbvie, Alcon, AVTRMed, Aurion, Bausch & Lomb, CorneaGen, Covalent, CRST, Crystilex, BVI, Blephex, ELT Sight, EyePoint Pharma, Foresight, Glaukos, Horizon Surgical Systems, Inversa, Johnson & Johnson, Kala, Katena, Lacripen, LayerBio, LensGen, Mati Pharmaceuticals, Melt Pharmaceuticals, MDBackline, MOA, Nordic Pharma, Novabay, Ocular Innovations, Oculis, Omega Ophthalmics, Ocuhub, PRN, Rayner, ReTear, Singular, Strathspey Crown, Surface, Tarsus, Tearscience, Tenpoint Pharma, Versant Ventures, Visionary Venture, and Zeiss
 

Nhon Le, MD
Assistant Professor, Department of Ophthalmology
Cornea, External Diseases, Cataract, and Refractive Surgery
University of Texas Southwestern Medical Center
Dallas, TX

Dr. Le has no relevant financial relationships with ineligible companies to disclose.
 

Kishan Patel, MD
Assistant Professor, Vitreoretinal Surgery
Residency Associate Program Director
Department of Ophthalmology
University of Texas Southwestern Medical Center
Dallas, TX

Dr. Patel has no relevant financial relationships with ineligible companies to disclose.

 

Ian Pitha, MD, PhD
Glaucoma Specialist
Associate Director of the Alan S. Crandall Center for Glaucoma Innovation at Moran Eye Center
University of Utah Salt
Lake City, Utah

Dr. Pitha discloses the following:
Consultant for: W.L. Gore and Associates. Advisory Board Member for: EyeX.
 

Walter Whitley, OD, MBA, FAAO
Director of Professional Relations and Education
Regional Medical Director – Mid-Atlantic
EyeCare Partners, LLC
Norfolk, VA

Dr. Whitley discloses the following: 
Advisory Board Member for: Alcon, Allergan, Bausch and Lomb, Bruder Healthcare, Science Based Health, Sun Pharmaceuticals, Tarsus Pharmaceuticals, Visus Pharmaceuticals. Consultant for: Alcon, Aldeyra Therapeutics, Allergan, Apellis Pharmaceuticals, CSI Dry Eye Inc., Epion, Glaukos, Harrow, 12-Vision, Inc., Iveric Bio, Mediprint Pharma, Nordic Pharma, OD Immersion, Regener-Eyes, Sight Sciences, Thea Pharmaceuticals, Trukera, Viatris. Speaker for: Alcon, Allergan, Apellis Pharmaceuticals, Bausch and Lomb.

All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Instructions

In order to receive CME/CE credits, participants must complete the pre-assessment questions, post-assessment, and program evaluation. Participants must also score at least 75% on the post-assessment. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Dashboard or Transcript, which you can access at any time.

Related products